Clinical Trial Update: Pharmacoscopy for Patients With Refractory Primary Brain Tumors [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for pharmacoscopy in patients with refractory primary brain tumors, currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Central Nervous System Neoplasms
• Ependymoma
• Glioblastoma
• Glioma
• Medulloblastoma
• Meningioma
• Rare Cns Neoplasms
• Rare Primary Brain Neoplasms

Snippet

Sponsor: University of Zurich | Conditions: Brain (Nervous System) Cancers, Glioblastoma | Phase 2 | Status: NOT_YET_RECRUITING